These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

131 related articles for article (PubMed ID: 2509055)

  • 1. Flagellar antibody stimulated opsonophagocytosis of Pseudomonas aeruginosa associated with response to either a- or b-type flagellar antigen.
    Anderson TR; Montie TC
    Can J Microbiol; 1989 Sep; 35(9):890-4. PubMed ID: 2509055
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Protection against Pseudomonas aeruginosa infection by passive transfer of anti-flagellar serum.
    Drake D; Montie TC
    Can J Microbiol; 1987 Sep; 33(9):755-63. PubMed ID: 3121159
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Enzyme-linked immunosorbent assay for detection of Pseudomonas aeruginosa H (flagellar) antigen.
    Montie TC; Anderson TR
    Eur J Clin Microbiol Infect Dis; 1988 Apr; 7(2):256-60. PubMed ID: 2455641
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Characterization of monoclonal antibodies to Pseudomonas aeruginosa type A flagellar antigen.
    Montie TC; Phillips D; Landsperger WJ
    Behring Inst Mitt; 1997 Feb; (98):424-33. PubMed ID: 9382766
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The first clinical trial of immuno's experimental Pseudomonas aeruginosa flagellar vaccines.
    Crowe BA; Enzersberger O; Schober-Bendixen S; Mitterer A; Mundt W; Livey I; Pabst H; Kaeser R; Eibl M; Eibl J
    Antibiot Chemother (1971); 1991; 44():143-56. PubMed ID: 1801633
    [No Abstract]   [Full Text] [Related]  

  • 6. Evaluation of flagella and flagellin of Pseudomonas aeruginosa as vaccines.
    Campodónico VL; Llosa NJ; Grout M; Döring G; Maira-Litrán T; Pier GB
    Infect Immun; 2010 Feb; 78(2):746-55. PubMed ID: 19995892
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Opsonophagocytosis of Pseudomonas aeruginosa treated with antiflagellar serum.
    Anderson TR; Montie TC
    Infect Immun; 1987 Dec; 55(12):3204-6. PubMed ID: 3119502
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pseudomonas aeruginosa flagellar antibodies in patients with cystic fibrosis.
    Anderson TR; Montie TC; Murphy MD; McCarthy VP
    J Clin Microbiol; 1989 Dec; 27(12):2789-93. PubMed ID: 2512326
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Flagella specific H antigenic schema of Pseudomonas aeruginosa (author's transl)].
    Ansorg R
    Zentralbl Bakteriol Orig A; 1978 Nov; 242(2):228-38. PubMed ID: 104481
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Opsonophagocytic killing activity of rabbit antibody to Pseudomonas aeruginosa mucoid exopolysaccharide.
    Ames P; DesJardins D; Pier GB
    Infect Immun; 1985 Aug; 49(2):281-5. PubMed ID: 3160660
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pseudomonas aeruginosa antigens as potential vaccines.
    Stanislavsky ES; Lam JS
    FEMS Microbiol Rev; 1997 Nov; 21(3):243-77. PubMed ID: 9451816
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Flagellar preparations from Pseudomonas aeruginosa: animal protection studies.
    Holder IA; Wheeler R; Montie TC
    Infect Immun; 1982 Jan; 35(1):276-80. PubMed ID: 6797948
    [TBL] [Abstract][Full Text] [Related]  

  • 13. An immunological study of the pili of Pseudomonas aeruginosa.
    Bradley DE; Pitt TL
    J Hyg (Lond); 1975 Jun; 74(3):419-30. PubMed ID: 807617
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Differentiation of the major flagellar antigens of Pseudomonas aeruginosa by the slide coagglutination technique.
    Ansorg RA; Knoche ME; Spies AF; Kraus CJ
    J Clin Microbiol; 1984 Jul; 20(1):84-8. PubMed ID: 6430957
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Opsonic and protective activity of five human IgM monoclonal antibodies reactive with lipopolysaccharide antigen of Pseudomonas aeruginosa.
    Collins MS; Ladehoff DK; Mehton NS; Noonan JS
    FEMS Microbiol Immunol; 1990 Dec; 2(5-6):263-8. PubMed ID: 2127368
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Preparation of agglutinating antisera specific for the flagellar antigens of Pseudomonas aeruginosa.
    Pitt TL
    J Med Microbiol; 1981 Aug; 14(3):251-60. PubMed ID: 6790705
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Inhibitory activity on bacterial motility and in vivo protective activity of human monoclonal antibodies against flagella of Pseudomonas aeruginosa.
    Ochi H; Ohtsuka H; Yokota S; Uezumi I; Terashima M; Irie K; Noguchi H
    Infect Immun; 1991 Feb; 59(2):550-4. PubMed ID: 1898908
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Opsonic activity of anti-flagellar serum against Clostridium chauvoei by mouse polymorphonuclear leucocytes.
    Tamura Y; Tanaka M
    Vet Microbiol; 1987 May; 14(1):81-6. PubMed ID: 2442881
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Determination of the components of immune complexes made in vitro with antigens derived from Pseudomonas aeruginosa.
    Kronborg G; Fomsgaard A; Shand GH; Høiby N
    J Immunol Methods; 1989 Aug; 122(1):51-7. PubMed ID: 2569492
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Studies on phagocytosis of mucoid and nonmucoid variants of Pseudomonas aeruginosa. II. Induction of heterologous immunity by mucoid strains of P. aeruginosa.
    Gościniak G; Grzybek-Hryncewicz K
    Arch Immunol Ther Exp (Warsz); 1988; 36(2):185-93. PubMed ID: 3149177
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.